COGNITION THERAPEUTICS
0.5202
07-November-24 14:59:33
15 minutes delayed
Stocks
+0.0204
+4.08%
Today's range
0.5081 - 0.5301
ISIN
N/A
Source
NASDAQ
-
21 Feb 2023 06:30:49 By Nasdaq GlobeNewswire
-
09 Feb 2023 07:00:38 By Nasdaq GlobeNewswire
-
22 Dec 2022 07:00:46 By Nasdaq GlobeNewswire
-
21 Dec 2022 15:05:00 By Nasdaq GlobeNewswire
-
15 Dec 2022 07:00:42 By Nasdaq GlobeNewswire
-
28 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Launches Neuroscience Thought Leader Conversations Podcast/Webinar Series
21 Nov 2022 07:00:33 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Closing of Public Offering
15 Nov 2022 11:55:47 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
14 Nov 2022 07:00:07 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of Public Offering
10 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
12 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Appoints CNS Drug Development Expert to VP Clinical Development
11 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
29 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
27 Sep 2022 06:32:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in September Investment Conferences
06 Sep 2022 06:32:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
09 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
04 Aug 2022 15:02:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
03 Aug 2022 15:05:00 By Nasdaq GlobeNewswire
-
19 Jul 2022 07:00:02 By Nasdaq GlobeNewswire